Tasso has launched Tasso Care, a “scalable” blood data collection platform built around its unique at-home blood collection kit and screening data system.

Blood-collection technology firm Tasso has been recommended for certification by MDSAP. The international qualification is part of a push to offer the company’s technology in countries such as Australia and Canada, CEO Ben Casavant told Medtech Insight. 

Tasso, which developed devices that allow patients to draw blood samples at home, wants to transform health care by supporting decentralized clinical trials, clinical research and remote patient health monitoring.